# Riley Exploration Permian, Inc.: financial statements, quarterly

REPX · NYSE · CIK 1001614 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/repx.md) · [Financials](/companies/repx/financials.md) · [Filings](/companies/repx/filings.md) · [Insiders](/companies/repx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/repx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [108](/filings/0001001614-24-000064.md) | [99.8 d](/filings/0001001614-26-000011.md) | [99.7](/filings/0001001614-25-000026.md) | [105](/filings/0001001614-25-000045.md) | [102](/filings/0001001614-25-000058.md) | [103 d](/filings/0001001614-26-000011.md) | [102](/filings/0001001614-26-000022.md) | [85.4](/filings/0001001614-26-000051.md) | [107](/filings/0001001614-25-000058.md) | [97.3 d](/filings/0001001614-26-000011.md) | [114](/filings/0001001614-26-000022.md) | [166](/filings/0001001614-26-000051.md) |
| Operating income | $m | [58.2](/filings/0001001614-24-000064.md) | [32.6 d](/filings/0001001614-26-000011.md) | [50.6](/filings/0001001614-25-000026.md) | [53.6](/filings/0001001614-25-000045.md) | [17.5](/filings/0001001614-25-000058.md) | [32.0 d](/filings/0001001614-26-000011.md) | [49.5](/filings/0001001614-26-000022.md) | [28.8](/filings/0001001614-26-000051.md) | [28.9](/filings/0001001614-25-000058.md) | [26.2 d](/filings/0001001614-26-000011.md) | [43.7](/filings/0001001614-26-000022.md) | [87.2](/filings/0001001614-26-000051.md) |
| Interest expense | $m | [10.3](/filings/0001001614-23-000040.md) | [10.3 d](/filings/0001001614-24-000010.md) | [9.1](/filings/0001001614-24-000024.md) | [8.9](/filings/0001001614-25-000045.md) | [8.8](/filings/0001001614-25-000058.md) | [7.6 d](/filings/0001001614-26-000011.md) | [6.7](/filings/0001001614-26-000022.md) | [7.2](/filings/0001001614-26-000051.md) | [9.6](/filings/0001001614-25-000058.md) | [7.9 d](/filings/0001001614-26-000011.md) | [6.4](/filings/0001001614-26-000022.md) | [6.8](/filings/0001001614-26-000051.md) |
| Income tax | $m | [3.9](/filings/0001001614-24-000064.md) | [11.4 d](/filings/0001001614-26-000011.md) | [5.8](/filings/0001001614-25-000026.md) | [10.7](/filings/0001001614-25-000045.md) | [7.0](/filings/0001001614-25-000058.md) | [4.6 d](/filings/0001001614-26-000011.md) | [8.2](/filings/0001001614-26-000022.md) | [9.7](/filings/0001001614-26-000051.md) | [4.8](/filings/0001001614-25-000058.md) | [25.4 d](/filings/0001001614-26-000011.md) | [(22.3)](/filings/0001001614-26-000022.md) | [27.3](/filings/0001001614-26-000051.md) |
| Net income | $m | [8.6](/filings/0001001614-24-000064.md) | [38.0 d](/filings/0001001614-26-000011.md) | [18.8](/filings/0001001614-25-000045.md) | [33.5](/filings/0001001614-25-000045.md) | [25.7](/filings/0001001614-25-000058.md) | [10.9 d](/filings/0001001614-26-000011.md) | [28.6](/filings/0001001614-26-000022.md) | [30.5](/filings/0001001614-26-000051.md) | [16.3](/filings/0001001614-25-000058.md) | [85.4 d](/filings/0001001614-26-000011.md) | [(70.4)](/filings/0001001614-26-000022.md) | [87.4](/filings/0001001614-26-000051.md) |
| Diluted EPS | $ per share | [0.43](/filings/0001001614-24-000064.md) | not reported | [0.94](/filings/0001001614-25-000026.md) | [1.59](/filings/0001001614-25-000045.md) | [1.21](/filings/0001001614-25-000058.md) | not reported | [1.36](/filings/0001001614-26-000022.md) | [1.44](/filings/0001001614-26-000051.md) | [0.77](/filings/0001001614-25-000058.md) | not reported | [(3.38)](/filings/0001001614-26-000022.md) | [4.11](/filings/0001001614-26-000051.md) |
| Basic EPS | $ per share | [0.44](/filings/0001001614-24-000064.md) | not reported | [0.94](/filings/0001001614-25-000026.md) | [1.61](/filings/0001001614-25-000045.md) | [1.22](/filings/0001001614-25-000058.md) | not reported | [1.36](/filings/0001001614-26-000022.md) | [1.44](/filings/0001001614-26-000051.md) | [0.77](/filings/0001001614-25-000058.md) | not reported | [(3.38)](/filings/0001001614-26-000022.md) | [4.17](/filings/0001001614-26-000051.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [10.4](/filings/0001001614-23-000040.md) | [15.3](/filings/0001001614-24-000010.md) | [6.6](/filings/0001001614-24-000024.md) | [10.9](/filings/0001001614-24-000048.md) | [13.3](/filings/0001001614-24-000064.md) | [13.1](/filings/0001001614-26-000011.md) | [8.9](/filings/0001001614-25-000026.md) | [14.0](/filings/0001001614-25-000045.md) | [16.5](/filings/0001001614-25-000058.md) | [17.9](/filings/0001001614-26-000051.md) | [15.8](/filings/0001001614-26-000022.md) | [20.7](/filings/0001001614-26-000051.md) |
| Current assets | $m | [67.2](/filings/0001001614-23-000040.md) | [63.3](/filings/0001001614-25-000012.md) | [58.8](/filings/0001001614-24-000024.md) | [61.9](/filings/0001001614-24-000048.md) | [75.3](/filings/0001001614-24-000064.md) | [68.1](/filings/0001001614-26-000011.md) | [53.8](/filings/0001001614-25-000026.md) | [67.0](/filings/0001001614-25-000045.md) | [79.4](/filings/0001001614-25-000058.md) | [93.8](/filings/0001001614-26-000051.md) | [83.1](/filings/0001001614-26-000022.md) | [104](/filings/0001001614-26-000051.md) |
| Total assets | $m | [953](/filings/0001001614-23-000040.md) | [946](/filings/0001001614-25-000012.md) | [956](/filings/0001001614-24-000024.md) | [1,003](/filings/0001001614-24-000048.md) | [998](/filings/0001001614-24-000064.md) | [994](/filings/0001001614-26-000011.md) | [995](/filings/0001001614-25-000026.md) | [1,034](/filings/0001001614-25-000045.md) | [1,191](/filings/0001001614-25-000058.md) | [1,170](/filings/0001001614-26-000051.md) | [1,180](/filings/0001001614-26-000022.md) | [1,270](/filings/0001001614-26-000051.md) |
| Current liabilities | $m | [107](/filings/0001001614-23-000040.md) | [94.3](/filings/0001001614-25-000012.md) | [99.8](/filings/0001001614-24-000024.md) | [97.6](/filings/0001001614-24-000048.md) | [107](/filings/0001001614-24-000064.md) | [123](/filings/0001001614-26-000011.md) | [122](/filings/0001001614-25-000026.md) | [105](/filings/0001001614-25-000045.md) | [127](/filings/0001001614-25-000058.md) | [157](/filings/0001001614-26-000051.md) | [264](/filings/0001001614-26-000022.md) | [232](/filings/0001001614-26-000051.md) |
| Total liabilities | $m | [564](/filings/0001001614-23-000040.md) | [524](/filings/0001001614-25-000012.md) | [522](/filings/0001001614-24-000024.md) | [514](/filings/0001001614-24-000048.md) | [490](/filings/0001001614-24-000064.md) | [483](/filings/0001001614-26-000011.md) | [463](/filings/0001001614-25-000026.md) | [477](/filings/0001001614-25-000045.md) | [625](/filings/0001001614-25-000058.md) | [535](/filings/0001001614-26-000051.md) | [627](/filings/0001001614-26-000022.md) | [637](/filings/0001001614-26-000051.md) |
| Long-term debt | $m | [365](/filings/0001001614-23-000040.md) | [336](/filings/0001001614-25-000012.md) | [322](/filings/0001001614-24-000024.md) | [303](/filings/0001001614-24-000048.md) | [269](/filings/0001001614-24-000064.md) | [249](/filings/0001001614-26-000011.md) | [229](/filings/0001001614-25-000026.md) | [255](/filings/0001001614-25-000045.md) | [347](/filings/0001001614-25-000058.md) | [228](/filings/0001001614-26-000051.md) | [221](/filings/0001001614-26-000022.md) | [247](/filings/0001001614-26-000051.md) |
| Current portion of debt | $m | [20.0](/filings/0001001614-23-000040.md) | [20.0](/filings/0001001614-25-000012.md) | [20.0](/filings/0001001614-24-000024.md) | [20.0](/filings/0001001614-24-000048.md) | [20.0](/filings/0001001614-24-000064.md) | [20.0](/filings/0001001614-26-000011.md) | [20.0](/filings/0001001614-25-000026.md) | [20.0](/filings/0001001614-25-000045.md) | [20.0](/filings/0001001614-25-000058.md) | [20.0](/filings/0001001614-26-000051.md) | [20.0](/filings/0001001614-26-000022.md) | [20.0](/filings/0001001614-26-000051.md) |
| Shareholders' equity | $m | [389](/filings/0001001614-24-000064.md) | [422](/filings/0001001614-26-000011.md) | [435](/filings/0001001614-25-000045.md) | [489](/filings/0001001614-25-000058.md) | [507](/filings/0001001614-25-000058.md) | [511](/filings/0001001614-26-000051.md) | [532](/filings/0001001614-26-000051.md) | [557](/filings/0001001614-26-000051.md) | [566](/filings/0001001614-25-000058.md) | [634](/filings/0001001614-26-000051.md) | [553](/filings/0001001614-26-000051.md) | [633](/filings/0001001614-26-000051.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [52.7 d](/filings/0001001614-24-000064.md) | [65.8 d](/filings/0001001614-26-000011.md) | [56.1](/filings/0001001614-25-000026.md) | [51.6 d](/filings/0001001614-25-000045.md) | [72.1 d](/filings/0001001614-25-000058.md) | [66.4 d](/filings/0001001614-26-000011.md) | [50.4](/filings/0001001614-26-000022.md) | [33.6 d](/filings/0001001614-26-000051.md) | [63.7 d](/filings/0001001614-25-000058.md) | [64.9 d](/filings/0001001614-26-000011.md) | [47.2](/filings/0001001614-26-000022.md) | [63.5 d](/filings/0001001614-26-000051.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [6.8 d](/filings/0001001614-24-000064.md) | [7.5 d](/filings/0001001614-26-000011.md) | [7.2](/filings/0001001614-25-000026.md) | [7.5 d](/filings/0001001614-25-000045.md) | [8.1 d](/filings/0001001614-25-000058.md) | [8.0 d](/filings/0001001614-26-000011.md) | [8.0](/filings/0001001614-26-000022.md) | [8.1 d](/filings/0001001614-25-000045.md) | [8.7 d](/filings/0001001614-25-000058.md) | [8.5 d](/filings/0001001614-26-000011.md) | [8.4](/filings/0001001614-26-000022.md) | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001001614-26-000022.md) | [0.0 d](/filings/0001001614-26-000051.md) | not reported | not reported | [4.0](/filings/0001001614-26-000022.md) | [0.9 d](/filings/0001001614-26-000051.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.6](/filings/0001001614-23-000040.md) | [19.9](/filings/0001001614-24-000024.md) | [20.0](/filings/0001001614-24-000048.md) | [20.0](/filings/0001001614-24-000064.md) | [20.0](/filings/0001001614-25-000026.md) | [21.1](/filings/0001001614-25-000045.md) | [21.2](/filings/0001001614-25-000058.md) | [21.1](/filings/0001001614-26-000022.md) | [21.2](/filings/0001001614-26-000051.md) | [21.3](/filings/0001001614-25-000058.md) | [20.9](/filings/0001001614-26-000022.md) | [21.3](/filings/0001001614-26-000051.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,400,032 at 2029-04-03, from the cover of the [10-K/A filed 2024-04-03](/filings/0001140361-24-017654.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.